SBIR TOPIC 251: DEVELOPMENT OF ANTICANCER AGENTS REQUESTOR: ALI ANDALIBI VEN

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N43CM0800027
Agency Tracking Number: N43CM0800027
Amount: $185,073.00
Phase: Phase I
Program: SBIR
Awards Year: 2008
Solicitation Year: 2008
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
GENESEGUES, INC., 3180 HIGH POINT DRIVE, CHASKA, MN, 55318
DUNS: 095972415
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Gretchen Unger
 () -
Business Contact
Phone: (952) 443-3798
Email: rtu@genesegues.com
Research Institution
N/A
Abstract
Metastatic spread of cancer cells is the primary cause of death in cancer patients and developing therapeutic agents that kill primary and disseminated cancer cells is an important topic. The aim of this project is to continue the development of a novel nanocapsule for the delivery of RNAi into tumor cells. Necessary studies to support the filing of an IND will be conducted. Potential off-targeting properties of the nanoencapsulated therapeutic will be investigated in tissue specimens.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government